Follow The Filings

AMN Amn Healthcare Services Inc.

Health Care, filed as AMN HEALTHCARE SVCS INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 2 managers in 2026 Q2

  • 2 Owners
  • Max 0.1%
  • $7.6M
  • 1 new 1 add

In 2026 Q2 First Eagle Investment Management opened a position in Amn Healthcare Services, and Tweedy, Browne Co. added.

Who owns this now

Largest portfolio weights among holders, up to 0.1% (Tweedy, Browne Co.). Not free-float ownership.

  1. Tweedy, Browne Co. Add 0.09%
  2. First Eagle Investment Manage... New 0.01%

Who owns AMN

Sorted by value, long equity only, as of 2026 Q2.

History
First Eagle Investment Management 0.01% New 0.01% 196,212 $6.4M History
Tweedy, Browne Co. 0.09%, was 0.04% Add +33.4% 37,299 $1.2M History

2 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by AMN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All AMN insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $114K sold by 1 insider under 10b5-1 plans
  1. Mark G Foletta Director
    Planned sale
    $114K 3,681 shares at $31.07 17% of stake
    Traded Jun 15 Filed Jun 17
    ↗

Also filed in the last 12 months, not counted as buying or selling: 26 option exercises and 16 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
8-K 9.01 Filing Doc
10-Q Filing Doc
8-K 9.01 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
10-K Filing Doc
8-K 9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 7.01 Filing Doc
8-K 5.03 Filing Doc

Source: SEC EDGAR submissions, updated 15 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $3.79B $2.98B $2.73B
Gross profit $1.25B $0.919B $0.774B
Gross margin * 33.0% 30.8% 28.3%
Net income $210.68M -$146.98M -$95.7M
Net margin * 5.6% -4.9% -3.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $841.68M $594.92M $545.38M
Total non-current assets * $2.08B $1.82B $1.55B
Total assets $2.92B $2.42B $2.09B
Total current liabilities $656.12M $545.78M $577.61M
Total non-current liabilities * $1.44B $1.16B $0.874B
Total equity $831.26M $706.62M $642.11M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $372.16M $320.42M $269.46M
Cash from investing -$412.49M -$79.94M $4.3M
Cash from financing $10.73M -$259.45M -$295.89M
Net change in cash -$29.6M -$18.97M -$22.13M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf